An experimental targeted therapy has shown promising results against melanoma driven by NRAS gene mutations, offering hope ...
A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a pathway-targeted therapy ...
Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a new therapeutic pathway for cancers driven by NRAS mutations. Findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results